Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
For You
Following
My Playlist
Explore more
Trending
Movie
Music
Gaming
Sports
News
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Treatment for Recurrent Endometrial Cancer: Chemothera
…
10 months ago
onclive.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem
…
Sep 15, 2022
touchoncology.com
2:05
Pembrolizumab for Urothelial Carcinoma
39.4K views
Mar 15, 2017
Facebook
The New England Journal of Medicine
Adverse Events Seen With Combination Lenvatinib and Pem
…
Dec 22, 2022
onclive.com
2:14
Quick Take: Neoadjuvant Pembrolizumab for Advanced Mel
…
2.3K views
Mar 2, 2023
Facebook
The New England Journal of Medicine
Dr Bellmunt on Enfortumab Vedotin/Pembrolizumab in the Co
…
4 months ago
onclive.com
0:51
Immunotherapy Breakthroughs in Cancer Treatment
152 views
2 months ago
YouTube
ScienceVids!
4:17
Real-World Management of Patients on Cemiplimab
581 views
Jun 11, 2019
YouTube
Targeted Oncology
3:14
Anti-PD-1 Treatment Selection
76 views
Aug 6, 2015
YouTube
AJMCtv
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer
Jul 2, 2018
targetedonc.com
12:56
Recent Updates in NCCN Guidelines for the Treatment of Recurrent or
…
8 months ago
onclive.com
2:57
KEYNOTE-412: pembrolizumab with CRT vs placebo plus CRT for local
…
133 views
Sep 12, 2022
YouTube
VJOncology
1:16
POCHI: pembrolizumab, CAPOX and bevacizumab in pMMR/MSS color
…
55 views
2 months ago
YouTube
VJOncology
3:30
FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) i
…
39 views
5 months ago
YouTube
U.S. Food and Drug Administration
2:35
Pembrolizumab/carboplatin/paclit
…
1.1K views
Nov 29, 2022
YouTube
ecancer
2:18
Pembrolizumab monotherapy and pembro-axitinib for RCC
251 views
Apr 8, 2019
YouTube
VJOncology
1:13
PD1 inhibitors in patients with cHL: the potential for combination ther
…
68 views
4 months ago
YouTube
VJHemOnc – Video Journal of Hematology & H…
3:15
Highlights on pembro + CRT in high-risk locally advanced cervic
…
2.5K views
11 months ago
YouTube
European Society for Medical Oncology (ESMO)
1:00
Pembrolizumab/Axitinib and Avelumab/Axitinib combo for RCC
222 views
Apr 8, 2019
YouTube
VJOncology
57:53
STR Cardiothoracic Case Webinar 1/9/2020
484 views
Jan 9, 2020
YouTube
Jeffrey Kanne
2:02
Progression on Pembrolizumab: Patient Without Actionable Mutati
…
54 views
Mar 2, 2023
YouTube
GRACE - Global Resource for Advancing Canc…
1:57
Keynote 091: Adjuvant Pembrolizumab - OncTalk Lung 2
…
47 views
5 months ago
YouTube
GRACE - Global Resource for Advancing Canc…
2:00
Keynote 671: Perioperative Pembrolizumab for NSCLC - OncT
…
50 views
5 months ago
YouTube
GRACE - Global Resource for Advancing Canc…
1:44
Extended Interval Dosing for Pembrolizumab - Lung Cancer On
…
49 views
Mar 2, 2023
YouTube
GRACE - Global Resource for Advancing Canc…
4:22
Melanoma immunotherapy latest and TVEC plus pembrolizumab
1.9K views
Nov 20, 2015
YouTube
ecancer
3:13
Pembrolizumab with Bevacizumab for Treatment of Metastatic Kidne
…
542 views
May 21, 2015
YouTube
Big Ten Cancer Research Consortium
4:20
KEYNOTE-522: 5-year follow-up of pembrolizumab in triple-negative
…
2.9K views
11 months ago
YouTube
VJOncology
7:33
EVITA Criteria to Identify Patients Unfit for EV/Pembro
1 views
1 month ago
YouTube
GU Oncology Now
0:28
Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymp
…
249 views
Mar 14, 2017
YouTube
OncLive
1:06
Exciting potential of pembrolizumab combined with axitinib for kidney
…
291 views
Sep 6, 2018
YouTube
VJOncology
See more videos
More like this
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Invisible focusable element for fixing accessibility issue
Feedback